Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea

NCT03508869 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped sponsor asked site to suspend study.

Conditions

Erythema and Flushing Associated With Rosacea

Interventions

DRUG: Mirvaso® (brimonidine) topical gel, 0.33%
DRUG: Dysport®
DRUG: Dysport® in conjunction with Mirvaso (brimonidine) topical gel, 0.33%

Sponsor

Skin Laser & Surgery Specialists

Collaborators

[object Object]